prabotulinumtoxin A: Clinical Trials

15 trials of prabotulinumtoxin A, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 2 terminated, 1 recruiting, 1 unknown. 6 Phase 2, 3 Early Phase 1, 2 Not applicable, 2 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 4, Terminated 2
Early Phase 13Completed 2, Unknown 1
Not applicable2Completed 2
Phase 42Completed 1, Recruiting 1
Phase 11Completed 1

Follow prabotulinumtoxin A: new trials by email Literature Review of prabotulinumtoxin A trials Research Report on prabotulinumtoxin A

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Dry Needling and Two Botulinum Toxins for Bruxism
Dry Needling (DN), PrabotulinumtoxinA, Abobotulinumtoxina - Bruxism, Sleep Bruxism, Adult
Not applicableCompletedRecep Tayyip Erdogan University722026-01-092026-05-20
BoTox Into the Sternocleidomastoid Muscles (SCM)
prabotulinumtoxinA-xvfs - Neck Muscle Issue
Phase 4RecruitingBoston Medical Center302025-05-142026-08-31
Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture
PrabotulinumtoxinA-Xvfs, IncobotulinumtoxinA, saline solution (placebo) - Skin Aging, Skin Wrinkling
Phase 1CompletedKalpna Kay Durairaj, MD, FACS202024-09-032025-10-21
Spread of PrabotulinumtoxinA-xvfs Versus OnabotulinumtoxinA in the Treatment of Forehead Rhytides
PrabotulinumtoxinA-Xvfs, OnabotulinumtoxinA - Rhytides
Early Phase 1CompletedLupo Center for Aesthetic and General Dermatology102023-05-012024-03-13
Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines
prabotulinumtoxinA - Glabellar Frown Lines
CompletedEvolus, Inc.7562023-03-152026-06-30
Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy
Botulinum Toxin Type A - Pancreatic Carcinoma
Phase 2TerminatedOHSU Knight Cancer Institute42023-03-012025-05-13
Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines
PrabotulinumtoxinA-Xvfs, OnabotulinumtoxinA - Glabellar Frown Lines
Phase 2CompletedEvolus, Inc.1542022-03-302024-09-04
Evaluation of Four Injectable Neuromodulators in the Glabella Area Glabella Area
Onabotulinumtoxina for Injection, Abobotulinumtoxina for Injection, IncobotulinumtoxinA for Injection - Cosmetic Techniques
Not applicableCompletedUniversity of Pennsylvania1432022-03-042025-01-17
Jeuveau Treatment of Glabellar Lines Using OLD Versus COLD
prabotulinumtoxinA - Glabellar Frown Lines
Early Phase 1CompletedClinical Testing of Beverly Hills302021-12-162024-02-06
Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention
ABP-450 - Migraine
Phase 2TerminatedAEON Biopharma, Inc.4662021-10-192024-09-20
Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia
ABP-450 - Cervical Dystonia
Phase 2CompletedAEON Biopharma, Inc.512021-07-272024-08-22
A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia
ABP-450, Placebo - Cervical Dystonia
Phase 2CompletedAEON Biopharma, Inc.612021-03-292024-02-14
Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults
ABP-450, Placebo - Migraine
Phase 2CompletedAEON Biopharma, Inc.7972021-03-012024-09-04
Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines
PrabotulinumtoxinA, Onabotulinum toxin A - Glabellar Frown Lines
Early Phase 1UnknownUniversity of Southern California202021-01-012023-12-14
Efficacy of Prabotulinum and Onabotulinum Toxin-A for Facial Wrinkles
Onabotulinum toxin A, Prabotulinumtoxin A - Face, Skin Fold
Phase 4CompletedInstituto de Oftalmología Fundación Conde de Valenciana262020-06-152023-05-03

Conditions studied

Migraine Disorders (2)  ·  Torticollis (2)  ·  Bruxism (1)  ·  Facies (1)  ·  Masticatory Muscles, Hypertrophy of (1)  ·  Pancreatic Neoplasms (1)  ·  Sleep Bruxism (1)  ·  Temporomandibular Joint Disorders (1)

Sponsors

AEON Biopharma, Inc. (4)  ·  Evolus, Inc. (2)  ·  Boston Medical Center (1)  ·  Clinical Testing of Beverly Hills (1)  ·  Instituto de Oftalmología Fundación Conde de Valenciana (1)  ·  Kalpna Kay Durairaj, MD, FACS (1)  ·  Lupo Center for Aesthetic and General Dermatology (1)  ·  OHSU Knight Cancer Institute (1)  ·  Recep Tayyip Erdogan University (1)  ·  University of Pennsylvania (1)  ·  University of Southern California (1)

Countries

United States (12)  ·  Australia (2)  ·  Canada (2)  ·  Germany (1)  ·  Mexico (1)  ·  Turkey (Türkiye) (1)

Top investigators

Joseph Jankovic (2)  ·  Richard B Lipton, MD (2)  ·  Stewart J Tepper, MD (2)  ·  Brett C Sheppard, M.D., FACS (1)  ·  Cynthia Comella (1)  ·  Cynthia Comella, MD (1)  ·  Jeffrey Spiegel, MD (1)  ·  John Joseph, MD (1)  ·  Kalpna K Durairaj, MD (1)  ·  Rui Avelar (1)  ·  Rui Avelar, MD (1)  ·  Yonathan Garfias, PhD (1)

Results publications

PMID 25311357, PMID 26233808, PMID 30893169, PMID 40434770